Psilocybin shows therapeutic promise for several psychiatric disorders, but the acute perceptual and cognitive alterations produced by conventional doses (10-25 mg) require in-clinic supervision, which limits scalability. Whether the therapeutically relevant pharmacology of psilocybin can be separated from its hallucinogenic activity remains unresolved. To address this gap, we conducted a Phase...
This case report offers rare insights into crossmodal responses to psychedelic drug use in a congenitally blind (CB) individual as a form of synthetic synesthesia. BP's personal experience provides us with a unique report on the psychological and sensory alterations induced by hallucinogenic drugs, including an account of the absence of visual hallucinations, and a compelling look at the...
Abstract This paper explores the transformation of a dualistic mind-body relationship as reported by participants in a recent qualitative study involving modern yoga and meditation practitioners. The stories of the practitioners focused strongly on transforming a body-self that was configured as a result of living a life in Western cultural contexts where philosophies of mind-body dualisms were...